Evonile Pharma Limited

NOVARTIND.BO·BSE
Compare
1,922.90+22.25 (+1.17%)today
At close: Oct 19, 3:28 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1,900.65
Open1,874.95
Day range1,869.351,939.95
52-week range750.002,588.00
Off day high−0.88%
Off 52-week high−25.70%
Volume1.20K
Avg. volume (3M)9.56K
Market cap47.48B
EPS (TTM)39.61
Forward P/E—
P/E ratio (TTM)48.55
Dividend yield—
Beta (5Y)—
Shares outstanding24.69M
Short interest—
Earnings dateMay 9, 2025
Analyst target—
Profit margin—

Related companies

No related companies yet: the instruments index has no profile for NOVARTIS INDIA LTD..

Latest news

All NOVARTIND.BO news ›
Venture Intelligence News·

Evonile Pharma approves Rs.900-Cr rights issue

Mumbai-based Evonile Pharma (formerly known as Novartis India) would raise INR 900 crore through a rights issue. The transaction involves the issuance of… Public Market Secondary Issues Source Evonile Pharma (opens in a new tab)Rediff.com…

From articles in the 4Search news index.

In the news

7mentions in 30 days
7with it in the headline
Positivesentiment

Mentioned with

Novartis India7Novartis India Limited7Bandra-Kurla Complex5Ciba Pharma5Evonile Pharma Limited5Inspire Bkc5Manila Times5Memorandum of Association5

People in the coverage

Chandni Maru6Akebia5Vikas Gupta5Cantor4Glen Allen4Pragyan Kalita4

Themes

5635(C)(4)5Grants5Inducement5Listing5Nasdaq5Oct. 025Reports5Rule5

Most coverage from

  1. medicaldialogues.in4
  2. news.ventureintelligence.com1
  3. news18.com1
  4. tradingview.com1

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.